In vivo imaging of mineral deposition in carotid plaque using 18F-sodium fluoride PET/CT: Correlation with atherogenic risk factors

Journal of Nuclear Medicine

Volumn 52, Issue 3, 2011, Pages 362-368

  Derlin, Thorsten ^a   Wisotzki, Christian ^a   Richter, Ulrich ^a   Apostolova, Ivayla ^b   Bannas, Peter ^a   Weber, Christoph ^a   Mester, Janos ^a   Klutmann, Susanne ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

18F sodium fluoride; Atherosclerosis; Calcification; Cardiovascular risk factors; Carotid; PET CT; Plaque

Indexed keywords

SODIUM FLUORIDE F 18;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; PRIORITY JOURNAL; RADIOACTIVITY; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; CALCINOSIS; CAROTID ARTERY DISEASES; COMORBIDITY; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY; PREVALENCE; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; SODIUM FLUORIDE; STATISTICS AS TOPIC; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79952792328     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.081208     Document Type: Article

References (33)

1. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 1988;12:56-62.
2. Dennis MS, Bamford JM, Sandercock PA, et al. A comparison of risk factors and prognosis for transient ischemic attacks and minor ischemic strokes. The Oxfordshire Community Stroke Project. Stroke. 1989;20:1494-1499.
3. JM UK-I. Young V, Gillard JH. Carotid-artery imaging in the diagnosis and management of patients at risk of stroke. Lancet Neurol. 2009;8:569-580.
4. Trivedi RA, U-King-Im JM, Graves MJ, et al. Non-stenotic ruptured atherosclerotic plaque causing thrombo-embolic stroke. Cerebrovasc Dis. 2005;20:53-55. (Pubitemid 41003639)
5. Doherty TM, Asotra K, Fitzpatrick LA, et al. Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci USA. 2003;100:11201-11206. (Pubitemid 37205912)
6. Chen W, Bural GG, Torigian DA, et al. Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging. 2009;36:144-151.
7. Spagnoli LG, Mauriello A, Sangiorgi G, et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA. 2004;292:1845-1852. (Pubitemid 40169295)
8. Virmani R, Burke AP, Farb A, et al. Pathology of the unstable plaque. Prog Cardiovasc Dis. 2002;44:349-356. (Pubitemid 34535156)
9. 18F-FDG PET/CT. J Nucl Med. 2004;45:1816-1821.
10. Tahara N, Kai H, Ishibashi M, et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2006;48:1825-1831. (Pubitemid 44648621)
11. 18F-FDG uptake with vascular calcification. J Nucl Med. 2005;46:1278-1284.
12. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J Nucl Med. 2009;50:1611-1620.
13. Saam T, Rominger A, Wolpers S, et al. Association of inflammation of the left anterior descending coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: a PET/CT study. Eur J Nucl Med Mol Imaging. 2010;37:1203-1212.
14. 18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708-2711.
15. 18F-fluoromethylcholine PET/CT for imaging of vessel wall alterations in humans; first results. Eur J Nucl Med Mol Imaging. 2008;35:815-820.
16. 11C-choline uptake and calcification in aortic and common carotid arterial walls with combined PET/CT. Eur J Nucl Med Mol Imaging. 2009;36:1622-1628.
17. Laitinen IE, Luoto P, Nagren K, et al. Uptake of 11C-choline in mouse atherosclerotic plaques. J Nucl Med. 2010;51:798-802.
18. 18F- sodium fluoride PET/CT for imaging of atherosclerotic plaque. J Nucl Med. 2010;51:862-865.
19. O'Malley PG, Taylor AJ, Jackson JL, et al. Prognostic value of coronary electronbeam computed tomography for coronary heart disease events in asymptomatic populations. Am J Cardiol. 2000;85:945-948. (Pubitemid 30176130)
20. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847. (Pubitemid 28213628)
21. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174. (Pubitemid 8054849)
22. 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008;49:871-878.
23. Bural GG, Torigian DA, Chamroonrat W, et al. FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging. 2008;35:562-569. (Pubitemid 351674338)
24. Saam T, Yuan C, Chu B, et al. Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging. Atherosclerosis. 2007;194:e34-e42. (Pubitemid 47513067)
25. Miida T, Hirayama S, Nakamura Y. Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia. J Atheroscler Thromb. 2004;11:253-264.
26. Hofbauer LC, Brueck CC, Shanahan CM, et al. Vascular calcification and osteoporosis: from clinical observation towards molecular understanding. Osteoporos Int. 2007;18:251-259. (Pubitemid 46233170)
27. Schinke T, McKee MD, Karsenty G. Extracellular matrix calcification: where is the action? Nat Genet. 1999;21:150-151.
28. Schinke T, Karsenty G. Vascular calcification: a passive process in need of inhibitors. Nephrol Dial Transplant. 2000;15:1272-1274.
29. Engelse MA, Neele JM, Bronckers AL, et al. Vascular calcification: expression patterns of the osteoblast-specific gene core binding factor alpha-1 and the protective factor matrix gla protein in human atherogenesis. Cardiovasc Res. 2001;52:281-289. (Pubitemid 33000405)
30. Dhore CR, Cleutjens JP, Lutgens E, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2001;21:1998-2003. (Pubitemid 34219753)
31. Jeziorska M, McCollum C, Wooley DE. Observations on bone formation and remodelling in advanced atherosclerotic lesions of human carotid arteries. Virchows Arch. 1998;433:559-565. (Pubitemid 28561189)
32. Yoshimoto M, Waki A, Obata A, et al. Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate. Nucl Med Biol. 2004;31:859-865. (Pubitemid 39297683)
33. 18F-FDG PET/CT: when to image? J Nucl Med. 2009;50:854-857.